Literature DB >> 8965207

Ethical clinical practice of functional brain imaging. Society of Nuclear Medicine Brain Imaging Council.

.   

Abstract

The development and evolution of functional brain imaging technology and their broad application to a wide range of neurological and psychiatric disorders have led to their scientifically sound use in specific clinical situations. In addition, there is a growing diversity of empirical new applications where there is little previous research or clinical experience. Therefore, a committee of the Brain Imaging Council of the Society of Nuclear Medicine was formed to address the need for specific guidelines regarding scan interpretation and reporting. This committee considered the wide range of current and potential uses of PET and SPECT, including its growing role in forensics. A set of basic guidelines for the reporting and interpretation of brain imaging studies applicable to all clinical situations, including forensics, was formulated. These guidelines were composed in a manner sensitive to the need for standards that are scientifically defensible now, and which will continue to be valid as the field evolves. It is the intent of the committee and its summary document to positively influence the clinical use of brain SPECT and PET by offering guidance concerning the elements essential to a complete and useful clinical report, defining standards to differentiate well-established clinical applications from research uses and providing a framework in which to consider the appropriateness of functional brain imaging used in the forensic arena.

Entities:  

Mesh:

Year:  1996        PMID: 8965207

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  5 in total

1.  FDG-PET: procedure guidelines for tumour imaging.

Authors:  Emilio Bombardieri; Cumali Aktolun; Richard P Baum; Angelika Bishof-Delaloye; John Buscombe; Jean François Chatal; Lorenzo Maffioli; Roy Moncayo; Luc Mortelmans; Sven N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12       Impact factor: 9.236

2.  Guidelines for the ethical use of neuroimages in medical testimony: report of a multidisciplinary consensus conference.

Authors:  C C Meltzer; G Sze; K S Rommelfanger; K Kinlaw; J D Banja; P R Wolpe
Journal:  AJNR Am J Neuroradiol       Date:  2013-08-29       Impact factor: 3.825

3.  EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2.

Authors:  Andrea Varrone; Susanne Asenbaum; Thierry Vander Borght; Jan Booij; Flavio Nobili; Kjell Någren; Jacques Darcourt; Ozlem L Kapucu; Klaus Tatsch; Peter Bartenstein; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

4.  EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2.

Authors:  Ozlem L Kapucu; Flavio Nobili; Andrea Varrone; Jan Booij; Thierry Vander Borght; Kjell Någren; Jacques Darcourt; Klaus Tatsch; Koen J Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

5.  EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2.

Authors:  Koen Van Laere; Andrea Varrone; Jan Booij; Thierry Vander Borght; Flavio Nobili; Ozlem L Kapucu; Zuzana Walker; Kjell Någren; Klaus Tatsch; Jacques Darcourt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.